|1.||Qiu, Yong: 8 articles (01/2014 - 01/2006)|
|2.||Dauchy, Robert T: 7 articles (10/2011 - 02/2002)|
|3.||Wang-Weigand, Sherry: 7 articles (10/2011 - 09/2007)|
|4.||Blask, David E: 7 articles (10/2011 - 02/2002)|
|5.||Sauer, Leonard A: 6 articles (10/2011 - 02/2002)|
|6.||Roth, Thomas: 6 articles (10/2011 - 07/2007)|
|7.||Laudon, Moshe: 5 articles (12/2015 - 01/2014)|
|8.||Jockers, Ralf: 5 articles (06/2015 - 01/2005)|
|9.||Reiter, Russel J: 5 articles (05/2015 - 10/2011)|
|10.||Wolf, Beate: 5 articles (12/2014 - 01/2008)|
03/15/2014 - "Piromelatine, a novel melatonin receptor agonist, stabilizes metabolic profiles and ameliorates insulin resistance in chronic sleep restricted rats."
04/03/2013 - "Loss-of-function mutations in the melatonin receptor are associated with insulin resistance and type 2 diabetes. "
09/01/2010 - "Removal of melatonin receptor type 1 induces insulin resistance in the mouse."
07/15/2013 - "Exogenous melatonin ameliorates insulin resistance in animals, while among humans, polymorphisms in the melatonin receptor gene are associated with insulin resistance. "
09/01/2010 - "In this study, we report that removal of melatonin receptor type 1 (MT1) significantly impairs the ability of mice to metabolize glucose and such inability is probably due to an increased insulin resistance in these mice. "
|3.||Sleep Initiation and Maintenance Disorders (Insomnia)
06/01/2015 - "Based on the fact that MT1 receptors are involved in human sleep onset process, melatonin receptor agonists have been developed to treat insomnia. "
12/01/2011 - "Melatonin receptor agonists: new options for insomnia and depression treatment."
01/01/2008 - "Hence, there is an urgent need for the development of melatonin receptor agonists with a longer half-life, which could be suitable for a successful treatment of insomnia. "
05/01/2000 - "Presentations ranged from the basic science of melatonin receptors to the epidemiology of untreated insomnia, and finally, to the education of primary care physicians. "
10/01/2011 - "Association of polymorphism in the promoter of the melatonin receptor 1A gene with schizophrenia and with insomnia symptoms in schizophrenia patients."
01/01/2012 - "The purpose of this study was to investigate whether genetic variants in the melatonin receptor 1B (MTNR1B) gene are associated with delirium. "
01/01/2012 - "Polymorphisms in the melatonin receptor 1B gene and the risk of delirium."
10/01/2013 - "Melatonin receptor agonists may be effective for the treatment of delirium in elderly patients with acute stroke."
10/01/2013 - "Melatonin receptor agonists for treating delirium in elderly patients with acute stroke."
12/01/2012 - "We successfully treated five cases of delirium within 1 day with ramelteon, a novel selective melatonin receptor agonist. "
01/01/2009 - "In the last years a variety of melatonin receptor agonists have been synthesized and evaluated for the treatment of sleep disorders. "
04/01/2003 - "BMS-214778 is a novel melatonin receptor agonist that may be a useful treatment for sleep disorders that result from disruption of circadian rhythms. "
02/01/2010 - "The development of agents that are selective for melatonin receptors provides opportunity to further elucidate the actions of melatonin and its receptors and to develop novel treatments for specific types of sleep disorders. "
09/12/2002 - "To develop a new therapeutic agent for sleep disorders, we synthesized a novel series of tricyclic indan derivatives and evaluated them for their binding affinity to melatonin receptors. "
02/01/2011 - "Ramelteon, an MT(1)/MT(2) melatonin receptor agonist, is used for the treatment of sleep-onset insomnia and circadian sleep disorders. "
|5.||GTP-Binding Proteins (G-Protein)
|6.||Messenger RNA (mRNA)
|7.||Melatonin Receptors (Melatonin Receptor)
|1.||Phototherapy (Light Therapy)
|2.||Heterologous Transplantation (Xenotransplantation)
|3.||Drug Therapy (Chemotherapy)
|5.||Complementary Therapies (Alternative Medicine)